ECPG vs ATLC vs RPRX Stock Comparison

Encore Capital, Atlanticus Holdings and Royalty Pharma Prices as of Nov 13, 2026 Peers: Industry group
1 more company in this comparison (MTA) Create a free account to keep reading and compare up to 10 companies.
ECPG Encore Capital Group Inc
$109.49 +8.6% 1M +124.2% 1Y
Market cap
$2.28B
P/E
6.5x
Revenue (TTM)
$1.99B
Div. yield
–
Specialty Finance Financial Services
4 wins
ATLC Atlanticus Holdings Corp
$83.42 -8.4% 1M +56.4% 1Y
Market cap
$1.24B
P/E
5.7x
Revenue (TTM)
$2.96B
Div. yield
–
Specialty Finance Financial Services
4 wins
RPRX Royalty Pharma plc
$69.31 +17.5% 1M +74.5% 1Y
Market cap
$30.51B
P/E
45.4x
Revenue (TTM)
$2.62B
Div. yield
–
Specialty Finance Financial Services
3 wins

Head to Head

11 decided of 12

Atlanticus Holdings leads on 4 of the 12 questions below (Atlanticus Holdings 4, Encore Capital 4, Royalty Pharma 3). Which ones matter depends on what you are buying for; a cheap multiple and slow growth often come together.

QuestionECPGATLCRPRXLeader
Larger companyMarket capitalisation $2.28B $1.24B $30.51B RPRX
Cheaper on earningsLower P/E, profitable companies only 6.5x 5.7x 45.4x ATLC
Cheaper on forward earningsLower price / next fiscal year consensus EPS 6.5x 8.2x 12.2x ECPG
Faster revenue growthRevenue growth, trailing twelve months +27.2% +87.9% +11.4% ATLC
More profitableNet margin, trailing twelve months 17.7% 7.4% 25.7% RPRX
Better return on capitalReturn on invested capital 11.3% 22.7% — ATLC
Less leveragedLower net debt / EBITDA 5.1x 2.7x — ATLC
Higher dividend yieldTrailing dividend yield 0.00% 0.00% 0.00% –
Better 1-year returnPrice return, last 12 months +124.2% +56.4% +74.5% ECPG
Better 5-year returnAnnualised price return, 5 years +13.2%/yr +1.2%/yr +10.6%/yr ECPG
Less volatileAnnualised volatility, 1 year 41.1% 54.0% 22.1% RPRX
Higher overall scoreMean of the five percentile scores vs peers 70/100 68/100 54/100 ECPG

Percentile Scorecard

ECPGATLCRPRX

Each axis is the mean percentile of its metrics against the company's industry group. 100 is the best in the group, 50 the middle.

Scores by Axis

AxisECPGATLCRPRX
Valuation 71 #51 of 173 96 #8 of 173 17 #143 of 173
Growth 91 #17 of 169 95 #10 of 169 76 #42 of 169
Profitability 83 #28 of 156 94 #10 of 156 95 #9 of 156
Financial Health 29 #116 of 164 32 #112 of 164 72 #46 of 164
Shareholder Returns 75 #35 of 136 24 #104 of 136 10 #123 of 136
Overall 70 68 54
  • ECPG ranked among 176 companies in Lending and Credit
  • ATLC ranked among 176 companies in Lending and Credit
  • RPRX ranked among 176 companies in Lending and Credit

Price Performance

Price return, split-adjusted, before dividends. Click a name to hide or show it.

Returns

PeriodECPGATLCRPRXSPY
1 month +8.6%-8.4%+17.5% -2.0%
3 months +5.5%-18.7%+18.3% -2.8%
6 months +34.1%+8.1%+31.1% +2.0%
Year to date +101.5%+24.6%+79.4% +10.6%
1 year +124.2%+56.4%+74.5% +12.2%
3 years +147.9%+154.4%+151.9% +68.1%
3 years, per year +35.4%+36.5%+36.1% +18.9%
5 years +85.7%+6.4%+65.3% +61.4%
5 years, per year +13.2%+1.2%+10.6% +10.1%
10 years +329.4%+2,626.1%— +248.5%
10 years, per year +15.7%+39.2%— +13.3%

Risk

MeasureECPGATLCRPRXSPY
Volatility, 1Y 41.1%54.0%22.1% 13.6%
Downside volatility, 1Y 33.3%59.1%21.0% 13.9%
Beta vs S&P 500, 1Y 0.111.360.23 1.00
Return / volatility, 1Y 3.021.043.36 0.90
Max drawdown, 5Y -62.5%-71.1%-45.6% -25.4%
From 52-week high -13.2%-25.4%-1.0% -3.2%
52-week high $126.17$111.79$70.01 $779.14
52-week low $47.72$47.96$38.09 $631.97

Valuation History

Weekly multiples on trailing twelve-month fundamentals. Negative or extreme readings (a loss year, a collapsed denominator) are left out so the chart stays readable.

MultipleECPGATLCRPRX
P/E now vs peer median 6.7xmedian 11.6x 5.8xmedian 11.6x 46.0xmedian 11.6x
P/S now vs peer median 1.2xmedian 2.5x 0.4xmedian 2.5x 15.2xmedian 2.5x
EV/EBITDA now vs peer median 7.9xmedian 9.5x 3.3xmedian 9.5x —median 9.5x
P/FCF now vs peer median 15.1xmedian 4.7x 1.2xmedian 4.7x 13.4xmedian 4.7x
P/B now vs peer median 2.1xmedian 0.7x 1.6xmedian 0.7x 4.1xmedian 0.7x
PEG now vs peer median 0.03median 0.32 0.14median 0.32 0.79median 0.32

Financial History

Reported figures by fiscal period, placed on the calendar year (or quarter) each period ended in, so companies with different fiscal years line up.

Trailing twelve monthsECPGATLCRPRX
Revenue $1.99B $2.96B $2.62B
Gross profit – $2.74B –
Operating income $774.89M $2.14B $1.50B
Net income $350.91M $224.33M $1.17B
Free cash flow $151.46M $1.08B $2.96B
R&D – – $251.40M
EPS (diluted) $15.77 $11.38 $1.21
Cash & equivalents $158.43M $600.50M $513.66M
Total debt $4.24B $6.45B $8.59B
Shares (diluted) 22.26M 19.22M 557.00M
Enterprise value $1.56B -$1.18B $27.88B

All Metrics

58 metrics · best in bold

Bold marks the best reading: the lowest positive value for multiples, leverage and payout, the highest for everything else. The bar under each value is its percentile against that company's own peers. Hover a value for its rank and the peer median.

Valuation

12 metrics
MetricECPGATLCRPRX
P/E 6.7x 5.8x 46.0x
P/FCF 15.1x 1.2x 13.4x
P/Operating cash flow 13.0x 1.2x 13.4x
P/S 1.2x 0.4x 15.2x
P/B 2.1x 1.6x 4.1x
P/Tangible book 2.1x 1.6x 4.1x
EV/EBITDA 7.9x 3.3x –
EV/EBIT 8.2x 3.3x 32.0x
EV/Revenue 3.2x 2.4x 18.3x
EV/FCF 42.1x 6.6x 16.2x
EV/Operating cash flow 36.1x 6.6x 16.2x
PEG (3Y EPS CAGR) 0.03 0.14 0.79

Growth

14 metrics
MetricECPGATLCRPRX
Revenue growth (1Y) 27.2% 87.9% 11.4%
Revenue CAGR (3Y) 19.0% 38.5% 4.0%
Gross profit growth (1Y) – 90.1% –
Gross profit CAGR (3Y) – 39.1% –
Operating income growth (1Y) 142.9% 94.6% -2.4%
Operating income CAGR (3Y) 49.6% 38.8% 55.6%
Net income growth (1Y) 877.6% 91.8% -9.9%
Net income CAGR (3Y) 246.7% 31.2% 46.6%
EPS growth (1Y) 921.8% 104.0% -11.6%
EPS CAGR (3Y) 256.9% 40.4% 57.9%
Operating cash flow growth (1Y) 10.3% 119.0% 23.1%
Operating cash flow CAGR (3Y) 0.9% 36.2% 2.0%
Free cash flow growth (1Y) 14.7% 121.8% 23.1%
Free cash flow CAGR (3Y) 2.9% 37.0% 2.0%

Profitability

14 metrics
MetricECPGATLCRPRX
Gross margin – 92.4% –
EBITDA margin 40.4% 73.7% –
Operating margin 39.0% 72.2% 57.1%
Pretax margin 22.8% 9.5% 44.8%
Net margin 17.7% 7.4% 25.7%
FCF margin 7.6% 36.5% 113.1%
Operating cash flow margin 8.9% 36.5% 113.1%
Return on equity 32.5% 29.7% 12.0%
Return on assets 6.2% 2.9% 6.0%
Return on invested capital 11.3% 22.7% –
Return on capital employed – – 8.1%
Asset turnover 0.4x 0.4x 0.1x
Cash conversion (OCF / net income) 0.5x 4.8x 2.5x
Stock comp / revenue 1.0% 0.3% –

Financial Health

11 metrics
MetricECPGATLCRPRX
Debt / assets 74.6% 82.9% 44.1%
Debt / equity 3.9x 7.9x 0.9x
Net debt / EBITDA 5.1x 2.7x –
Debt / FCF 28.0x 6.0x 2.9x
Liabilities / assets 81.0% 89.6% 49.7%
Equity / assets 19.0% 10.4% 50.3%
Interest coverage 2.6x 4.4x 4.0x
Current ratio – – 1.3x
Quick ratio – – 0.5x
Cash ratio – – 0.5x
Altman Z-score – – 3.06

Shareholder Returns

7 metrics
MetricECPGATLCRPRX
Dividend yield – – 1.6%
Net buyback yield 5.6% 0.1% –
Shareholder yield 5.6% 0.1% 1.6%
Payout ratio (earnings) – – –
Payout ratio (FCF) – – –
Dividend growth (1Y) – – –
Dividend CAGR (3Y) – – –

Analyst Estimates

Solid lines are reported fiscal-year results; dashed lines are the consensus for the years ahead. Hover a year for the analysts' high and low, and how each result compared with its estimate.

ConsensusECPGATLCRPRX
Forward P/E 6.5xFY2026 8.2xFY2026 12.2xFY2026
EPS, next fiscal year $16.72FY2026 $10.21FY2026 $5.69FY2026
EPS growth, next FY +53.3%FY2026 +71.3%FY2026 +17.8%FY2026
EPS growth, the year after +5.4% +36.4% +9.5%
Revenue, next fiscal year $1.92BFY2026 $3.17BFY2026 $3.78BFY2026
Revenue growth, next FY +8.4%FY2026 +60.8%FY2026 +16.3%FY2026
Revenue growth, the year after +10.5% +12.4% +7.8%

Institutional Ownership

13F filings, quarter ended Jun 30, 2026
HoldersECPGATLCRPRX
Held by institutions 100.0% 26.0% 82.2%
Institutions holding 283 146 643
Change in shares held, QoQ -3.8% +7.9% +2.7%
Institutions buying 159 93 395
Institutions selling 91 36 179
Buyers to sellers 1.75 2.58 2.21

Return Correlation

Daily returns, last 12 months

1.00 means two stocks move in lockstep, 0 that they move independently. Pairs below about 0.5 diversify each other.

ECPGATLCRPRX
ECPG 1.00 0.35 0.04
ATLC 0.35 1.00 0.05
RPRX 0.04 0.05 1.00

Add a Peer

Largest companies in the same industry

Related Comparisons

Frequently Asked Questions

Which is bigger, ECPG, ATLC and RPRX?

Royalty Pharma (RPRX) is the largest by market capitalisation: Encore Capital (ECPG) $2.28B, Atlanticus Holdings (ATLC) $1.24B, Royalty Pharma (RPRX) $30.51B.

Which stock is cheaper, ECPG, ATLC and RPRX?

Atlanticus Holdings (ATLC) trades on the lowest price-to-earnings ratio (Encore Capital (ECPG) 6.5x, Atlanticus Holdings (ATLC) 5.7x, Royalty Pharma (RPRX) 45.4x). On next year's consensus earnings, Encore Capital (ECPG) is cheapest (Encore Capital (ECPG) 6.5x, Atlanticus Holdings (ATLC) 8.2x, Royalty Pharma (RPRX) 12.2x). A lower multiple can reflect slower expected growth, so read it next to the growth figures.

Which company is growing faster?

Atlanticus Holdings (ATLC) grew revenue fastest over the trailing twelve months: Encore Capital (ECPG) +27.2%, Atlanticus Holdings (ATLC) +87.9%, Royalty Pharma (RPRX) +11.4%.

Which company is more profitable?

Royalty Pharma (RPRX) has the highest net margin (Encore Capital (ECPG) 17.7%, Atlanticus Holdings (ATLC) 7.4%, Royalty Pharma (RPRX) 25.7%). On return on invested capital, Atlanticus Holdings (ATLC) leads (Encore Capital (ECPG) 11.3%, Atlanticus Holdings (ATLC) 22.7%).

Which stock has performed better?

Over the past year Encore Capital (ECPG) returned the most: Encore Capital (ECPG) +124.2%, Atlanticus Holdings (ATLC) +56.4%, Royalty Pharma (RPRX) +74.5%. Over five years, Encore Capital (ECPG) compounded fastest (Encore Capital (ECPG) +13.2%/yr, Atlanticus Holdings (ATLC) +1.2%/yr, Royalty Pharma (RPRX) +10.6%/yr). Returns are price only, before dividends.

Which stock is riskier?

By one-year price volatility, Royalty Pharma (RPRX) has been the steadiest (Encore Capital (ECPG) 41.1%, Atlanticus Holdings (ATLC) 54.0%, Royalty Pharma (RPRX) 22.1%). Volatility measures how widely the price swings, not the risk of the business.

Which is the better stock, ECPG, ATLC and RPRX?

There is no single answer; it depends on what you are buying for. On the 12 head-to-head measures on this page, Atlanticus Holdings (ATLC) leads on 4. Business Quant does not give investment advice; use the comparison as a starting point for your own research.

Data from SEC filings, exchange prices and consensus estimates, via Business Quant. Percentile scores compare each company with its own peer group, so two companies' scores are each relative to different peers unless you rank against the whole market. Price returns exclude dividends. Nothing on this page is investment advice.